News  

Renovion, Inc. ("Renovion"), an early stage drug development company targeting the treatment of lung transplant and other chronic...

Two Chapel Hill-based startups — EpiCypher and Renovion — attended the first University Startups Demo Day in Washington, D.C. On Tuesday,...

Of the more than 800 startups created at universities across the country this year, only 35 have been handpicked as the best and earned...

In a tiny lab in Chapel Hill, a 3-year-old startup with UNC-Chapel Hill technology is trying to help lung transplant patients defy the...

- Patent claims set foundation for commercialization - Board and management team in place to execute pre-clinical plan CHAPEL HILL, N.C.,...